banner
Reference Listed Drugs
Kyprolis 60mg Carfilzomib For Injection Reference Listed Drug

Kyprolis 60mg Carfilzomib For Injection Reference Listed Drug

Kyprolis is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two previous treatments, including proteasome inhibitors and immunomodulators. For R&D purposes only.

Product Details

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic name Carfilzomib for Injection
Trade name Kyprolis
Specification 60mg/vial
Main ingredients Carfilzomib
Appearance Kyprolis single use sterile vial containing 60 mg, white to pale carfilzomib lyophilized cake or powder.
MA Holder Onyx Pharmaceuticals,Inc.
Manufacturer Patheon Manufacturing Services, LLC
Indications

 

Kyprolis is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two previous treatments, including proteasome inhibitors and immunomodulators.
 

The indications were conditionally approved based on objective response rate results from a one-arm clinical trial.
 

Full approval of this product is subject to the results of a confirmatory clinical trial.

 

 

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

Hot Tags: Kyprolis 60mg Carfilzomib For Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adefovir Dipivoxil Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Reference Listed Drugs, AdapaleneGel, Olanzapine Tablets, Acarbose Tablets

Send Inquiry
Verification Code: